Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma

Journal of Clinical Ultrasound

Volumn 39, Issue 8, 2011, Pages 447-453

  Li, Chaolun ^a   Wang, Wenping ^a   Ding, Hong ^a   Huang, Beijian ^a   Cao, Jiaying ^a   Mao, Feng ^a   Ji, Zhengbiao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Contrast media; Liver; Neoplasm; Peripheral cholangiocarcinoma; Sonography

Indexed keywords

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; INTRAHEPATIC BILE DUCT; MALE; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RETROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 80052550699     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20797     Document Type: Article

References (24)

1. Han JK, Choi BI, Kim AY, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002; 22: 173.
2. Colli A, Cocciolo M, Mumoli N, et al. Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Eur J Ultrasound 1998; 7: 93.
3. Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001; 176: 1499.
4. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66: 167.
5. Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging 2004; 29: 540.
6. Choi BI, Lee JM, Han JK. Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging 2004; 29: 548.
7. Yamamoto M, Ariizumi S, Otsubo T, et al. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol 2004; 87: 80.
8. Yamamoto T, Takeuchi K, Okuda C, et al. Two small intrahepatic cholangiocarcinomas with different sonographic appearances. J Clin Ultrasound 2001; 29: 344.
9. Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR Am J Roentgenol 1995; 165: 1427.
10. Albrecht T, Blomley MJK, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361.
11. Leen E, Ceccotti P, Kalogeropoulou C, et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol 2006; 186: 1551.
12. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images: concordance of US scans with CT scans and MRI images. Radiology 2007; 242: 162.
13. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 2008; 29: 28.
14. Ding H, Wang WP, Huang BJ, et al. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005; 24: 285.
15. Wibulpolprasert B, Dhiensiri T. Peripheral cholangiocarcinoma: sonographic evaluation. J Clin Ultrasound 1992; 20: 303.
16. Xu HX, Liu GJ, Lu MD, et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006; 34: 261.
17. Li R, Guo Y, Hua X, et al. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 2007; 35: 109.
18. Morin SHX, Lim AKP, Cobbold JFL, et al. Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. World J Gastroenterol 2007; 13: 5963.
19. Xu HX, Lu MD, Liu GJ, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006; 25: 23.
20. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004; 24: 921.
21. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 2006; 238: 150.
22. Wilson SR, Kim TK, Jang HJ, et al. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 2007; 189: W7.
23. Xu HX, Chen LD, Xie XY, et al. Enhancement pattern of hilar cholangiocarcinoma: Contrast-enhanced ultrasound versus contrast-enhanced computed tomography. Eur J Radiol 2010; 75: 197.
24. Chen LD, Xu HX, Xie XY, et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 2010; 20: 743.